Navigation Links
Bacteria use host's immune response to their competitive advantage

Millions of bacteria live within the recesses of our noses and upper respiratory tracts, waiting for a chance to infiltrate and infect. But long before these bacteria break through our immune defenses, they must first compete against other bacterial species to colonize the mucus-lined surfaces of our noses.

Competition between two common nose bacteria involves some interesting trickery, according to a new study in PLoS Pathogens. "We're looking at how bacteria use their host, and we've found that the presence of one species leads to the elimination of another," says Jeffrey Weiser, coauthor of the study and professor of pediatrics and microbiology at the University of Pennsylvania, School of Medicine.

In a mouse model, Haemophilus influenzae--a common bacterium that infects children--stimulates the immune system to send out specialized white blood cells that attack its competitor, Streptococcus pneumoniae--a leading cause of pneumonia. "It is striking that the host's response can so completely eliminate the competitor," says Weiser.

The findings also demonstrate how antibiotics and vaccines that target one microbe might inadvertently alter the competitive interactions among other species present.

###

Citation: Lysenko ES, Ratner AJ, Nelson AL, Weiser JN (2005) The role of innate immune responses in the outcome of interspecies competition for colonization of mucosal surfaces. PLoS Pathogens 1(1): e1.


'"/>

Source:Public Library of Science


Page: 1

Related biology news :

1. Bacteria collection sheds light on urinary tract infections
2. Solution to Pollution: New Bacteria Eats Toxic Waste
3. The Bacterias guide to survival
4. UF Researchers Map Bacterial Proteins That Cause Tooth Loss
5. Bacterial genome sheds light on synthesizing cancer-fighting compounds
6. Where Bacteria Get Their Genes
7. Bacteria feed on smelly breath (and feet)
8. New insight into autoimmune disease: Bacterial infections promote recognition of self-glycolipids
9. Say what? Bacterial conversation stoppers
10. Bacteria are key to green plastics, drugs
11. Researchers Discover Ancient Origins Of Tuberculosis-causing Bacteria
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/31/2016)... PROVIDENCE, R.I. , March 31, 2016  Genomics ... leadership of founding CEO, Barrett Bready , M.D., ... addition, members of the original technical leadership team, including ... Vice President of Product Development, Steve Nurnberg and Vice ... have returned to the company. Dr. Bready ...
(Date:3/23/2016)... 2016 Einzigartige ... und Stimmerkennung mit Passwörtern     ... MESG ), ein führender Anbieter digitaler Kommunikationsdienste, ... SpeechPro zusammenarbeitet, um erstmals dessen Biometrietechnologie einzusetzen. ... Möglichkeit angeboten, im Rahmen mobiler Apps neben ...
(Date:3/22/2016)... and SANDY, Utah , March ... operates the highest sample volume laboratory in ... and UNIConnect, leaders in clinical sequencing informatics and molecular ... of a project to establish the informatics infrastructure for ... NSO has been contracted by the Ontario Ministry ...
Breaking Biology News(10 mins):
(Date:6/24/2016)... 24, 2016 Epic Sciences unveiled a ... susceptible to PARP inhibitors by targeting homologous recombination ... The new test has already been incorporated into ... cancer types. Over 230 clinical trials ... pathways, including PARP, ATM, ATR, DNA-PK and WEE-1. ...
(Date:6/24/2016)... ... June 24, 2016 , ... Researchers at the Universita Politecnica ... in people with peritoneal or pleural mesothelioma. Their findings are the subject of a ... , Diagnostic biomarkers are signposts in the blood, lung fluid or tissue of ...
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... ... is pleased to announce the launch of their brand, UP4™ Probiotics, into Target ... over 35 years, is proud to add Target to its list of well-respected ...
(Date:6/23/2016)... - FACIT has announced the creation of a ... Propellon Therapeutics Inc. ("Propellon" or "the Company"), to ... of first-in-class WDR5 inhibitors for the treatment of ... an exciting class of therapies, possessing the potential ... patients. Substantial advances have been achieved with the ...
Breaking Biology Technology: